Though many are hoping for a COVID-19 vaccine by 2021, that timeline may not be realistic given the extensive clinical trials needed, according to researchers at Duke University. “I think it’s entirely possible, it’s possible that a vaccine will be approved this year. But not at scale. We won't have a lot of doses of this," said researcher David Riley. With direct-to-patient services available and a GMP global depot network, Yourway can support all phases of clinical trials internationally.